CN103436556A - 一种表达cd133的重组腺病毒及其用途 - Google Patents
一种表达cd133的重组腺病毒及其用途 Download PDFInfo
- Publication number
- CN103436556A CN103436556A CN2013103539620A CN201310353962A CN103436556A CN 103436556 A CN103436556 A CN 103436556A CN 2013103539620 A CN2013103539620 A CN 2013103539620A CN 201310353962 A CN201310353962 A CN 201310353962A CN 103436556 A CN103436556 A CN 103436556A
- Authority
- CN
- China
- Prior art keywords
- recombinant adenovirus
- plasmid
- cells
- recombinant
- albumen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310353962.0A CN103436556B (zh) | 2013-08-14 | 2013-08-14 | 一种表达cd133的重组腺病毒及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310353962.0A CN103436556B (zh) | 2013-08-14 | 2013-08-14 | 一种表达cd133的重组腺病毒及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103436556A true CN103436556A (zh) | 2013-12-11 |
CN103436556B CN103436556B (zh) | 2015-09-16 |
Family
ID=49690271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310353962.0A Active CN103436556B (zh) | 2013-08-14 | 2013-08-14 | 一种表达cd133的重组腺病毒及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103436556B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108931513A (zh) * | 2018-08-28 | 2018-12-04 | 河南省医药科学研究院 | 体外检测MUSK-Ab和LRP4-Ab的方法及试剂盒 |
CN111529690A (zh) * | 2020-06-17 | 2020-08-14 | 中国科学院昆明动物研究所 | 人cd133蛋白1-108肽段的新用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102766653A (zh) * | 2012-06-25 | 2012-11-07 | 西北农林科技大学 | 一种质粒型腺病毒载体pAd-PPARGC1A及其构建方法 |
CN102787102A (zh) * | 2012-09-04 | 2012-11-21 | 山东省农业科学院畜牧兽医研究所 | 猪α干扰素成熟蛋白重组腺病毒及其构建方法与应用 |
CN103205462A (zh) * | 2012-12-09 | 2013-07-17 | 西北农林科技大学 | 一种质粒型腺病毒载体pAd-IGF2及其构建方法和应用 |
-
2013
- 2013-08-14 CN CN201310353962.0A patent/CN103436556B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102766653A (zh) * | 2012-06-25 | 2012-11-07 | 西北农林科技大学 | 一种质粒型腺病毒载体pAd-PPARGC1A及其构建方法 |
CN102787102A (zh) * | 2012-09-04 | 2012-11-21 | 山东省农业科学院畜牧兽医研究所 | 猪α干扰素成熟蛋白重组腺病毒及其构建方法与应用 |
CN103205462A (zh) * | 2012-12-09 | 2013-07-17 | 西北农林科技大学 | 一种质粒型腺病毒载体pAd-IGF2及其构建方法和应用 |
Non-Patent Citations (1)
Title |
---|
STRAUSBERG,R.L.等: ""GenBank Accession No:BC012089.1"", 《GENBANK》, 6 August 2001 (2001-08-06), pages 1 - 4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108931513A (zh) * | 2018-08-28 | 2018-12-04 | 河南省医药科学研究院 | 体外检测MUSK-Ab和LRP4-Ab的方法及试剂盒 |
CN108931513B (zh) * | 2018-08-28 | 2021-11-19 | 河南省医药科学研究院 | 体外检测MUSK-Ab和LRP4-Ab的方法及试剂盒 |
CN111529690A (zh) * | 2020-06-17 | 2020-08-14 | 中国科学院昆明动物研究所 | 人cd133蛋白1-108肽段的新用途 |
Also Published As
Publication number | Publication date |
---|---|
CN103436556B (zh) | 2015-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Schreiner et al. | Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells | |
Vogels et al. | Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity | |
De Lima et al. | Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo | |
CN111778264B (zh) | 基于新型腺病毒载体Sad23L和/或Ad49L的新型冠状病毒肺炎疫苗 | |
Pavlova et al. | Disruption of gammaherpesvirus 68 gene 50 demonstrates that Rta is essential for virus replication | |
US20130243731A1 (en) | Oncolytic adenoviral vectors coding for monoclonal anti-ctla-4 antibodies | |
Šroller et al. | Seroprevalence rates of BKV, JCV, and MCPyV polyomaviruses in the general Czech Republic population | |
Lemiale et al. | Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41 | |
Coughlan et al. | In vivo retargeting of adenovirus type 5 to αvβ6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery | |
CN103937835A (zh) | 一种基于腺病毒AdC68的表达载体及其构建方法 | |
CN106318916B (zh) | 重组腺病毒、和四价腺病毒疫苗及其制备方法 | |
AU2019383423B2 (en) | Adenoviruses and methods for using adenoviruses | |
CN101619324B (zh) | 复制缺陷型重组腺病毒Ad41载体系统及其应用 | |
Yan et al. | Developing novel oncolytic adenoviruses through bioselection | |
CN103436556B (zh) | 一种表达cd133的重组腺病毒及其用途 | |
Madisch et al. | Phylogenetic analysis and structural predictions of human adenovirus penton proteins as a basis for tissue-specific adenovirus vector design | |
CN103555754A (zh) | 一种干酪乳杆菌菌影及其制备方法和应用 | |
JP2014523236A (ja) | 腫瘍溶解性強化B型ヒトアデノウイルスAd11突然変異体の構築とその応用 | |
CN109303916A (zh) | 焦亡相关蛋白gsdmd在制备菌蜕疫苗中的应用 | |
Ternovoi et al. | Productive replication of human adenovirus type 5 in canine cells | |
CN109868263A (zh) | 重组单纯疱疹病毒及其制备方法和应用、重组载体的构建方法及其应用 | |
Carette et al. | Replication‐dependent transgene expression from a conditionally replicating adenovirus via alternative splicing to a heterologous splice‐acceptor site | |
CN108514635A (zh) | 重组三价腺病毒疫苗及其构建方法 | |
Yamasaki et al. | Development of a method for effective amplification of human adenovirus 40 | |
Tang et al. | Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IX |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN ZHONGYUAN MEDICAL BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: SHEN ZHENG Effective date: 20140317 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100083 HAIDIAN, BEIJING TO: 518057 SHENZHEN, GUANGDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140317 Address after: The central Shenzhen city of Guangdong Province, 518057 Keyuan Road, Nanshan District science and Technology Park No. 15 Science Park Sinovac A-1-701 Applicant after: Shenzhen Zhongyuan biological science and Technology Medical Co Ltd Address before: 100083, -2, CAS Talent Exchange Center, No. 25 West Fourth Ring Road, Beijing, Haidian District (3) Applicant before: Shen Zheng |
|
ASS | Succession or assignment of patent right |
Owner name: SHEN ZHENG Free format text: FORMER OWNER: SHENZHEN ZHONGYUAN MEDICAL BIOTECHNOLOGY CO., LTD. Effective date: 20150730 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150730 Address after: 510000 Guangdong city of Guangzhou province Tianhe District 8 Building Room 705, mid levels Yong Jingyuan Applicant after: Shen Zheng Address before: The central Shenzhen city of Guangdong Province, 518057 Keyuan Road, Nanshan District science and Technology Park No. 15 Science Park Sinovac A-1-701 Applicant before: Shenzhen Zhongyuan biological science and Technology Medical Co Ltd |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |